Bain Capital Life Sciences Fund, L.P.'s Net Worth
$158 Million
Who is Bain Capital Life Sciences Fund, L.P.?
Bain Capital Life Sciences Fund, L.P. has an estimated net worth of $158 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Replimune Group, Inc., Annexon, Inc., and Aptinyx Inc..
SEC CIK
Bain Capital Life Sciences Fund, L.P.'s CIK is 0001687968
Past Insider Trading and Trends
2020 was Bain Capital Life Sciences Fund, L.P.'s most active year for acquiring shares with 7 total transactions. Bain Capital Life Sciences Fund, L.P.'s most active month to acquire stocks was the month of June. 2017 was Bain Capital Life Sciences Fund, L.P.'s most active year for disposing of shares, totalling 6 transactions. Bain Capital Life Sciences Fund, L.P.'s most active month to dispose stocks was the month of November. 2020 saw Bain Capital Life Sciences Fund, L.P. paying a total of $21,799,988.00 for 10,554,253 shares, this is the most they've acquired in one year. In 2019 Bain Capital Life Sciences Fund, L.P. cashed out on 3,350,000 shares for a total of $58,552,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -23.87% | -1.75M |
$22.03 | -$38,552,500.00 | 5.58M |
Nov 19
| |||
Form 4
| -17.92% | -1.60M |
$12.50 | -$20,000,000.00 | 7.33M |
May 29
| |||
Form 4
|
∞
| 8.93M |
$7.00 |
—
| 8.93M |
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.925
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.24% | -1.27M |
$7.88 | -$10,024,800.93 | 3.98M |
Dec 15 - Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RAPID MICRO BIOSYSTEMS, INC. (RPID) Snapshot price: $0.978
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.43M |
$20.00 |
—
| 8.43M |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.98M |
$17.00 |
—
| 3.98M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $7.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.84M |
$15.00 |
—
| 2.84M |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||